GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » EV-to-Revenue

Kyowa Kirin Co (TSE:4151) EV-to-Revenue : 2.50 (As of May. 03, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kyowa Kirin Co's enterprise value is 円1,050,961 Mil. Kyowa Kirin Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was 円420,650 Mil. Therefore, Kyowa Kirin Co's EV-to-Revenue for today is 2.50.

The historical rank and industry rank for Kyowa Kirin Co's EV-to-Revenue or its related term are showing as below:

TSE:4151' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.56   Med: 3.14   Max: 6.05
Current: 2.49

During the past 13 years, the highest EV-to-Revenue of Kyowa Kirin Co was 6.05. The lowest was 1.56. And the median was 3.14.

TSE:4151's EV-to-Revenue is ranked worse than
52.49% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs TSE:4151: 2.49

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-03), Kyowa Kirin Co's stock price is 円2667.50. Kyowa Kirin Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was 円782.45. Therefore, Kyowa Kirin Co's PS Ratio for today is 3.41.


Kyowa Kirin Co EV-to-Revenue Historical Data

The historical data trend for Kyowa Kirin Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co EV-to-Revenue Chart

Kyowa Kirin Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.13 4.45 3.84 3.83 3.22

Kyowa Kirin Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.79 3.22 2.98 2.57 2.42

Competitive Comparison of Kyowa Kirin Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's EV-to-Revenue falls into.



Kyowa Kirin Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Kyowa Kirin Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1050961.408/420650
=2.50

Kyowa Kirin Co's current Enterprise Value is 円1,050,961 Mil.
Kyowa Kirin Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円420,650 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyowa Kirin Co  (TSE:4151) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Kyowa Kirin Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2667.50/782.448
=3.41

Kyowa Kirin Co's share price for today is 円2667.50.
Kyowa Kirin Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円782.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyowa Kirin Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (TSE:4151) Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines